Analysis of the roles of asymptomatic and untraceable cases in SARS-CoV-2 spreading

Home > Archive>Volume 28, Issue 5, 2020 >386-389

Analysis of the roles of asymptomatic and untraceable cases in SARS-CoV-2 spreading
DOI:
                        
                    
CSTR:
                        
                    
Author:
                        LI Kai1,4LI Kai
Division of Stem Cell Regulation and Application, Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China;GeneTalks Biotech Co., Ltd., Changsha, Hunan 410010, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
LIAO Duanfang1LIAO Duanfang
Division of Stem Cell Regulation and Application, Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site
DAI Aiguo2,3DAI Aiguo
Department of Respiratory Diseases, Medical School, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China;Department of Respiratory Medicine, First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China
Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:1.Division of Stem Cell Regulation and Application, Institute of Innovation and Applied Research in Chinese Medicine, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China;GeneTalks Biotech Co., Ltd., Changsha, Hunan 410010, China)
Clc Number:R5
Fund Project:

Article

Figures

Metrics

Reference [24]

Cited by

Materials

Comments

Abstract:

Except for medical facilities, infected cases without symptom, with different severity of symptoms, and lethal cases are resulted from the interactions between the pathogen and the host. It is necessary to note that the relationship between epidemic untraceable and asymptomatic cases has some values in guiding the prevention and foreseeing the trends of a new outbreak of infectious disease.

Key words:infected cases without symptom; infected cases with untraceable epidemic origin; SARS-CoV-2

Reference

[1] Prem K, Liu Y, Russell TW, et al.The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China:a modelling study.Lancet Glob Health, 2020.DOI:10.1016/S2468-2667(20)30073-6.

[2] Zhao S, Lin Q, Ran J, et al.Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020:a data-driven analysis in the early phase of the outbreak .Int J Infect Dis, 0,2:214-217.

[3] Li K, Deng J, Huang RB, et al.Suppressing R0 requires the identification of super spreader by genetic screening of individuals without fever.Int J Family Med P Care, 2020.DOI:https://dx.doi.org/10.25107/IJFMPC-v1-id1006.

[4] Wang C, Horby PW, Hayden FG, et al.A novel coronavirus outbreak of global health concern .Lancet, 0,5(10223):470-473.

[5] Bai Y, Yao L, Wei T, et al.Presumed asymptomatic carrier transmission of COVID-19 .JAMA, 2020.DOI:10.1001/jama.2020.2565.

[6] Rothe C, Schunk M, Sothmann P, et al.Transmission of 2019-nCoV infection from an asymptomatic contact in Germany .N Engl J Med, 0,2(10):970-971.

[7] Wlfel R, Corman VM, Guggemos W.et al.Virological assessment of hospitalized patients with COVID-2019 .Nature, 2020.DOI:10.1038/s41586-020-2196-x.

[8] Day M.Covid-19:four fifths of cases are asymptomatic, China figures indicate .BMJ, 2020.DOI:10.1136/bmj.m1375.

[9] 杨冬梅, 传军, 罗迪贤, 等.SARS-CoV-2暴露剂量与COVID-19潜伏期及病情发展趋势的相关性研究.中南医学科学杂志, 0,8(2):122-127.

[10] Jin Y, Yang H, Ji W, et al.Virology, epidemiology, pathogenesis, and control of COVID-19 .Viruses, 0,2(4):E372.

[11] Sarzi-Puttini P, Giorgi V, Sirotti S, et al.COVID-19, cytokines and immunosuppression:what can we learn from severe acute respiratory syndrome?.Clin Exp Rheumatol, 0,8(2):337-342.

[12] Carinci F.Covid-19:preparedness, decentralisation, and the hunt for patient zero .BMJ, 2020.DOI:10.1136/bmj.m799.

[13] How researchers cleared the name of HIV Patient Zero .Nature, 6,8(7626):428.

[14] Nishiura H, Jung SM, Linton NM, et al.The extent of transmission of novel coronavirus in Wuhan, China, 2020.J Clin Med, 0,9(2):330.

[15] Mario Ritter Jr.Thousands trapped on cruise ship in Japan over COVID-19 virus fears[R/OL].(2020-02-14)[2020-03-28].https://www.51voa.com/VOA_Special_English/thousands-trapped-on-cruise-ship-in-japan-over-covid--virus-fears-83897.html.

[16] Zhang J, Tian S, Lou J, et al.Familial cluster of COVID-19 infection from an asymptomatic.Crit Care, 0,4(1):119.

[17] Yu P, Zhu J, Zhang Z, et al.A familial cluster of infection associated with the 2019 novel coronavirus indicating potential person-to-person transmission during the incubation period.J Infect Dis, 2020.DOI:10.1093/infdis/jiaa077.

[18] Lee RS, Proulx JF, McIntosh F, et al.Previously undetected super-spreading of Mycobacterium tuberculosisrevealed by deep sequencing.Elife, 2020.DOI:10.7554/eLife.53245.

[19] Wilson ME, Chen LH.Travellers give wings to novel coronavirus (2019-nCoV) .J Travel Med, 0,7(2).DOI:10.1093/jtm/taaa015.

[20] Lauer SA, Grantz KH, Bi Q, et al.The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases:estimation and application.Ann Intern Med, 2020.DOI:10.7326/M20-0504.

[21] Pedersen SF, Ho YC.SARS-CoV-2:a storm is raging.J Clin Invest, 2020.DOI:10.1172/JCI137647.

[22] Yan Y, Chang L, Wang L.Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV):current status, challenges, and countermeasures.Rev Med Virol, 2020.DOI:10.1002/rmv.2106.

[23] Zhai P, Ding Y, Wu X, et al.The epidemiology, diagnosis and treatment of COVID-19.Int J Antimicrob Agents, 2020.DOI:10.1016/j.ijantimicag.2020.105955.

[24] Cucinotta D, Vanelli M.WHO declares COVID-19 a pandemic.Acta Biomed, 0,1(1):157-160.

Get Citation

LI Kai, LIAO Duanfang, DAI Aiguo. Analysis of the roles of asymptomatic and untraceable cases in SARS-CoV-2 spreading[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2020,28(5):386-389.

Copy

Article Metrics

Abstract:652
PDF: 732
HTML: 0
Cited by: 0

History

Received:April 03,2020
Revised:April 20,2020
Adopted:
Online: May 26,2020
Published:

Policies & Instructions

Get Citation

Share

Article Metrics

History

Article QR Code